Deletion or blockage of C1q, C3, or CR3 [65] in mouse models of Alzheimer’s disease has been shown to protect synapses and prevent cognitive impairments, highlighting the therapeutic potential of complement inhibition strategies [66]. The gene discussed is C3; the disease is Alzheimer disease.